Martin Erixon

No más puestos en curso

Health Technology

Consumer Services

Process Industries

Perfil

Martin Erixon formerly worked at Hamlet BioPharma AB, as Chief Executive Officer from 2022 to 2023, Hamlet BioPharma AB, as Chief Executive Officer from 2023 to 2025, Gambro AB, as Manager-Research & Development Project, and Tetra Pak AB, as Manager-Research & Development Project from 2011 to 2022.
Mr. Erixon received his doctorate degree in 2007 from the University of Lund.

Antiguos cargos conocidos de Martin Erixon.

Empresas	Cargo	Fin
HAMLET PHARMA AB (PUBL)	Director Ejecutivo	18/02/2025
HAMLET PHARMA AB (PUBL)	Director Ejecutivo	01/10/2023
Tetra Pak AB Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products	Corporate Officer/Principal	01/06/2022
Gambro AB Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Martin Erixon.

Formación de Martin Erixon.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Martin Erixon.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Gambro AB Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products	Health Technology
University of Lund University of Lund Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tetra Pak AB Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products	Process Industries
Hamlet BioPharma AB Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients	Health Technology